// App-Quantinova.ai

: An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in Alzheimer’s disease

Researchers

Presenter

  • Yuanbing JIANG

Principal Investigators

  • Hiu Yi Wong

  • Ouyang Li

  • Fanny C. F. Ip

  • Vicky M.N. Chau

  • Shun-Fat Lau

  • Wei Wu

  • Daniel Y.K. Wong

  • Heukjin Seo

  • Wing-Yu Fu

  • Nicole Chit Hang Lai

  • Yuewen Chen

  • Yu Chen

  • Estella Pui-Sze Tong

  • Vincent C.T. Mok

  • Timothy CY Kwok

  • Kin Y Mok

  • Maryam Shoai

  • Benoit Lehallier

  • Patricia Moran-Losada

  • Eleanor O’Brien

  • Tenielle Porter

  • Simon M Laws

  • John A. Hardy

  • Tony Wyss-Coray

  • Colin L. Masters

  • Amy K.Y. Fu

  • Nancy Y. Ip

Medical Centers

  • Paul F. Glenn Center for the Biology of Aging, Stanford University School of Medicine

  • Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Geriatrics, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin

  • UK Dementia Research Institute, University College London

  • Institute for Advanced Study, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon

  • Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park

  • Wu Tsai Neurosciences Institute, Stanford University School of Medicine

  • Centre for Precision Health, Edith Cowan University

  • Palo Alto Health Care System, CA

  • Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon

  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA

  • Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University

  • National Dementia Diagnostics Laboratory, The Florey Institute of Neuroscience and Mental Health

  • The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

  • School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University

  • Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong

  • Department of Neurodegenerative Disease, UCL Institute of Neurology

  • Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science

Locations

  • Hong Kong

  • United Kingdom

  • Philippines

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved